NPPA puts cap on prices of 51 essential medicines
November 25, 2017 2:59 am The National Pharmaceutical Pricing Authority (NPPA) on Friday stated that it has capped prices of 51 essential medicines, including those used for the treatment of cancer, pain, heart conditions and skin problems. According to an NPPA official, who spoke on the condition of anonymity, the prices have been slashed in the range of 6 to 53 per cent. Through separate notifications, the drug price regulator has notified ceiling prices of 36 medicines. Moreover, it has revised the ceiling prices of 15 medicines. Drugs whose ceiling prices have been capped include colon or rectal cancer treatment drug oxaliplatin (injection 100mg), Japanese encephalitis vaccine and measles rubbela vaccine. Ceiling prices of drugs, including anaesthetic sevoflurane, Phytomenadione (Vitamin K1) and tuberculosis prevention medicine BCG vaccine have been revised. NPPA fixes ceiling price of essential medicines that are listed in Schedule I of the Drugs (Prices Control) Order (DP...